Cribstone Capital Management’s Editas Medicine EDIT Stock Holding History

Cribstone Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-132	Closed	-$3K	–	420
2019 Q3	$3K	Hold	132	–	–	﹤0.01%	506
2019 Q2	$3K	Hold	132	–	–	﹤0.01%	551
2019 Q1	$3K	Hold	132	–	–	﹤0.01%	585
2018 Q4	$3K	Hold	132	–	–	﹤0.01%	619
2018 Q3	$4K	Hold	132	–	–	﹤0.01%	642
2018 Q2	$5K	Hold	132	–	–	﹤0.01%	614
2018 Q1	$4K	Buy	132 +27	+26%	+$962	﹤0.01%	631
2017 Q4	$3K	Hold	105	–	–	﹤0.01%	737
2017 Q3	$3K	Hold	105	–	–	﹤0.01%	642
2017 Q2	$2K	Hold	105	–	–	﹤0.01%	658
2017 Q1	$2K	Buy	+105	New	+$2.18K	﹤0.01%	684

Other funds holding EDIT

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Cribstone Capital Management's EDIT Position: Q4 2019 in Review

Cribstone Capital Management sold out of Editas Medicine (EDIT) in Q4 2019, closing a stake of 132 shares — an estimated $3K sold.

Cribstone Capital Management first reported a position in EDIT in Q1 2017 and held it in 11 quarters. The position peaked at $5K in Q2 2018. 229 funds tracked by Wall St. Rank hold EDIT as of Q4 2019.

Cribstone Capital Management reported no remaining Editas Medicine position as of Q4 2019 after selling out during the quarter.
Cribstone Capital Management sold 132 Editas Medicine shares in Q4 2019, an estimated $3K.
Cribstone Capital Management first reported a position in Editas Medicine in Q1 2017 and held it in 11 quarters.
Cribstone Capital Management's Editas Medicine position peaked at $5K in Q2 2018.
229 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2019.

Based on Cribstone Capital Management's 13F filing for Q4 2019, filed 8 Jan 2020.